Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution. [PDF]
Rev Bras Epidemiol, 2023 Gonçalves DS +5 more
europepmc +1 more source
Clinical characteristics of patients with Breast and / or Ovarian Cancer with mutations in the BRCA1 and BRCA2 genes in Córdoba, Argentina [PDF]
Rev Fac Cien Med Univ Nac Cordoba, 2022 Martin CA +9 more
europepmc +1 more source
[Cognitive deficits with chemotherapy in women with breast cancer: a bibliographic revisión] [PDF]
Rev Fac Cien Med Univ Nac Cordoba, 2023 Arce B, Grañana N.
europepmc +1 more source
Hormone therapy and cancer risks in transgender people: a systematic review. [PDF]
Epidemiol Serv SaudeUchimura LYT +5 more
europepmc +1 more source
Oncological safety of nipple-sparing mastectomy after neoadjuvant chemotherapy: a systematic review. [PDF]
Rev Col Bras Cir, 2023 Nissen L +4 more
europepmc +1 more source
Risk factors for the development of endometrial lesions in breast cancer patients using tamoxyphen: a retrospective cohort study. [PDF]
Rev Col Bras Cir, 2023 Vizzotto AO +3 more
europepmc +1 more source
The impact on body image and quality of life in breast cancer patients. [PDF]
Rev Bras EnfermMastrangelli AKF, Pinto VL, Elias S.
europepmc +1 more source
Incidence of radiodermatitis in breast cancer patients during hypofractionated radiotherapy. [PDF]
Rev Esc Enferm USP, 2022 Vieira LAC +6 more
europepmc +1 more source
Five-year overall and specific survival of breast cancer in great Cuiaba (MT), Brazil. [PDF]
Rev Bras EpidemiolOliveira JCS +3 more
europepmc +1 more source
Exclusive breastfeeding after breast cancer. Case study. [PDF]
Invest Educ Enferm, 2023 Poupas Martins MA, Sim-Sim M.
europepmc +1 more source